These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Photodynamic therapy in melanoma--an update. Baldea I; Filip AG J Physiol Pharmacol; 2012 Apr; 63(2):109-18. PubMed ID: 22653896 [TBL] [Abstract][Full Text] [Related]
14. Localization of radioactive lead in ocular and skin melanoma. Packer S; Lambrecht RM; Merrill JC; Atkins HL; Wolf AP Invest Ophthalmol; 1975 Jun; 14(6):492-4. PubMed ID: 1132948 [TBL] [Abstract][Full Text] [Related]
15. The promise of mTOR inhibitors in the treatment of colorectal cancer. Kim DD; Eng C Expert Opin Investig Drugs; 2012 Dec; 21(12):1775-88. PubMed ID: 22978346 [TBL] [Abstract][Full Text] [Related]
16. New drug targets in metastatic melanoma. Homet B; Ribas A J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077 [TBL] [Abstract][Full Text] [Related]
17. Genetic alterations and personalized medicine in melanoma: progress and future prospects. Griewank KG; Scolyer RA; Thompson JF; Flaherty KT; Schadendorf D; Murali R J Natl Cancer Inst; 2014 Feb; 106(2):djt435. PubMed ID: 24511108 [TBL] [Abstract][Full Text] [Related]
18. Ocular melanoma: a review and the relationship to cutaneous melanoma. Hurst EA; Harbour JW; Cornelius LA Arch Dermatol; 2003 Aug; 139(8):1067-73. PubMed ID: 12925397 [TBL] [Abstract][Full Text] [Related]
19. Somatic activation of KIT in distinct subtypes of melanoma. Curtin JA; Busam K; Pinkel D; Bastian BC J Clin Oncol; 2006 Sep; 24(26):4340-6. PubMed ID: 16908931 [TBL] [Abstract][Full Text] [Related]